Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
17.59
+0.42 (2.45%)
At close: Oct 9, 2026, 4:00 PM EDT
17.55
-0.04 (-0.23%)
After-hours: Oct 9, 2026, 7:58 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $14.07 billion as of October 9, 2026. It is the 1,619th most valuable company in the world and the 597th biggest in the United States. Its market cap has decreased by 18.86% in one year.
Market Cap
14.07B
Enterprise Value
13.40B
1-Year Change
-18.86%
Global Rank
Country Rank
#597 United States
Category
ChartMarket Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $14.07B, an increase of 11,721.17%. That is a compound annual growth rate of 50.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 14.03B | 7.77% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascendis Pharma | 15.08B |
| Exelixis | 14.85B |
| Jazz Pharmaceuticals | 14.24B |
| Corcept Therapeutics | 12.83B |
| BridgeBio Pharma | 12.69B |
| Halozyme Therapeutics | 12.53B |
| Bio-Techne | 11.36B |
| Madrigal Pharmaceuticals | 11.02B |